SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,960.0 Cr | 13.9% | 13.5% | -29.9% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹25,747.8 Cr | -0.9% | 2.9% | -31.2% | Stock Analytics | |
| SAGILITY INDIA | ₹23,088.3 Cr | -0.9% | -2.8% | 40.1% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,328.2 Cr | -7% | -4.2% | -2.6% | Stock Analytics | |
| JUST DIAL | ₹6,212.1 Cr | -1% | -3.1% | -34.2% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,514.7 Cr | -7.1% | -17.6% | -32.1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 13.9% |
13.5% |
-29.9% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses